Vivalytic tests

Our test portfolio is continuously being expanded.
The cartridge set is available in various sizes (6 or 9 liquid reagents) and is compatible with all Vivalytic laboratory equipment.

VRI multiplex test

VRI multiplex test

Application

The coronavirus (SARS-CoV-2) is responsible for the novel respiratory infection known as COVID-19. The infection emerged for the first time at the end of 2019 and has in the meantime spread around the globe. To date there is no specific treatment and no available vaccine that protects against coronavirus. The disease can be transmitted from person to person. The only way to stem the further spread of the disease is by diagnosing a person infected with COVID-19 early on and taking appropriate steps to contain and manage the disease. The Vivalytic VRI test (Viral Respiratory Tract Infections) checks the patient’s sample for the SARS CoV-2 virus, which can lead to COVID-19, as well as other possible viral respiratory diseases.

STI multiplex test

STI multiplex test

Application

Sexually transmitted infections present a major public health concern worldwide. However, many STIs are asymptomatic and some display similar or overlapping symptoms, thus co-infections may remain undiagnosed.

RTI multiplex test

RTI multiplex test

Application

Respiratory pathogens cause acute local and systemic illnesses with distinct severity. Diagnostics are complicated due to the number of viruses and bacteria that can cause such infections.